Immunologic effects of allogeneic versus autologous blood transfusion in patients undergoing radical oesophagectomy

European Surgical Research

Volumn 35, Issue 2, 2003, Pages 115-122

  Takemura, Masashi ^a   Osugi, H ^a   Takada, N ^a   Kinoshita, H ^a   Higashino, M ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Autologous blood transfusion; Natural killer cell activity; Oesophageal cancer

Indexed keywords

ADULT; AGED; ALLOTRANSPLANTATION; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; IMMUNOMODULATION; INFECTIOUS PNEUMONIA; INTERMETHOD COMPARISON; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL INFECTION; T LYMPHOCYTE SUBPOPULATION;

AGED; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 0037246579     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070025     Document Type: Article

References (37)

1. Duffy G, Kneal K: Differences in post-operative infection rates between patients receiving autologous and allogeneic blood transfusion: A meta-analysis of published randomized and nonrandomized studies. Transfus Med 1996;6:325-328.
2. Heiss M, Mempel W, Jauch KW, Delanoff C, Mayer G, Mempel M, Eissner HJ, Schildberg FW: Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 1993;342:1328-1333.
3. Foster R, Costanza M, Foster J, Wanner MC, Foster CB: Adverse relationship between blood transfusion and survival after colectomy for colon cancer. Cancer 1985;55:1195-1201.
4. Tartter P: Blood transfusion and infectious complications following colorectal cancer surgery. Br J Surg 1988;75:789-792.
5. Fong Y, Karpeh M, Mayer K, Brennan MF: Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. Am J Surg 1994;167:256-260.
6. Murphy P, Heal J, Blumberg N: Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusion. Transfusion 1991;31:212-217.
7. Lichtiger B, Huh Y, Armintor M, Fisher HE: Autologous transfusion for cancer patients undergoing elective ablative surgery. J Surg Oncol 1990;43:19-23.
8. O'Dwyer G, Mylotte M, Sweeney M, Egan EL: Experience of autologous blood transfusion in an obstetrics and gynaecology department. Br J Obstet Gynaecol 1993;100:571-574.
9. Goodnough L, Rudnick S, Price T, Ballas SK, Collins ML, Crowley JP, Kosmin M, Kruskall MS, Lenes BA, Menitove JE, Silberstein LE, Smith KJ, Wallas CH, Abels R, Trees MV: increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med 1989;321:1163-1168.
10. Braga M, Gianotti L, Vignali A, Gentilini O, Servida P, Bordignon C, Di Carlo V: Evaluation of recombinant human erythropoietin to facilitate autologous blood donation before surgery in anaemic patients with cancer of the gastrointestinal tract. Br J Surg 1995;82:1637-1640.
11. Kinoshita Y, Udagawa H, Tsutsumi K, Ueno M, Nakamura T, Akiyoshi H, Takahashi K, Kajiyama Y, Tsurumaru M: Usefulness of autologous blood transfusion for avoiding allogenic transfusion and infectious complications after esophageal cancer resection. Surgery 2000;127:185-192.
12. Oshimi K: Assay for NK cell activity. Clin Pathol 1981;45:299-309.
13. Maeta M, Shimizu N, Kondo A, Yamashiro H, Tsujitani S, Ikeguchi M, Kaibara N: Perioperative allogeneic blood transfusion exacerbates surgical stress-induced postoperative immunosuppression and has a negative effect on prognosis in patients with gastric cancer. J Surg Oncol 1994;55:149-153.
14. Sobin LH, Wittekind C (eds): TNM Classification of Malignant Tumors, ed 5. New York, Wiley, 1997.
15. Bancewicz J, Osugi H: Oesophagus epidemiology, investigation, and surgical management; in McCulloch P, Kingsnorth A (eds): Management of Gastrointestinal Cancer. London, BMJ, 1996, pp 97-123.
16. Grimes D: A simplified device for intraoperative autotransfusion. Obstet Gynecol 1988;72: 947-950.
17. Heiss M, Mempel W, Delanoff C, Jauch KW, Gabka C, Mempel M, Dieterich HJ, Eissner HJ, Schildberg FW: Blood transfusion-modulated tumor recurrence: First results of a randomized study of autologous versus allogeneic blood transfusion in colorectal surgery. J Clin Oncol 1994;12:1859-1867.
18. Jeekel J: Autologous blood donation and epoetin alfa in cancer surgery. Semin Hematol 1996;33:43-47.
19. Flordal P, Bergqvist D: Possible benefit of pre-operative blood deposit for abdominal surgery. World J Surg 1997;21:349-352.
20. Sutton DN, Wayman J, Griffin SM: Learning curve for oesophageal cancer surgery. Br J Surg 1998;85:1399-1402.
21. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW: Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 1987;316:73-78.
22. Moriguchi S, Maehara Y, Akazawa K, Sugimachi K, Nose Y: Lack of relationship between perioperative blood transfusion and survival time after curative resection for gastric cancer. Cancer 1990;66:2331-2335.
23. Choi JH, Chung HC, Yoo NC, Lee HR, Lee KH, Kim JH, Roh JK, Min JS, Lee KS, Kim BS, Lim HY: Perioperative blood transfusions and prognosis in patients with curatively resected locally advanced gastric cancer. Oncology 1995;52:170-175.
24. Nathanson SD, Tilley BC, Schultz L, Smith RF: Perioperative allogeneic blood transfusions. Survival in patients with resected carcinomas of the colon and rectum. Arch Surg 1985;120:734-738.
25. Voogt PJ, van de Velde CJ, Brand A, Hermans J, Stijnen T, Bloem R, Leer JW, Zwaveling A, van Rood JJ: Perioperative blood transfusion and cancer prognosis. Different effects of blood transfusion on prognosis of colon and breast cancer patients. Cancer 1987;59:836-843.
26. Quintiliani L, Pescini A, Di Girolamo M, Iudicone P, Martini F, Guglielmetti M, Buzzonetti A, Fascioli S: Relationship of blood transfusion, post-operative infections and immunore-activity in patients undergoing surgery for gastrointestinal cancer. Haematologica 1997;82:318-323.
27. Okabayashi T, Tanaka N, Satomi S, Suzuki H, Takagi H, Takahashi T, Saito Y, Touge T, Sugimachi K, Orita K: Efficiency of autologous blood transfusion using recombinant human erythropoietin and postoperative cell mediated immunity in patients with gastrointestinal cancer. Jpn J Gastroenterol Surg 1999;32:2339-2349.
28. Jensen L, Andersen A, Christiansen P, hokland P, Juhl CO, Madsen G, Mortensen J, Moller-Nielsen C, Hanberg-Sorensen F, Hokland M: Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992;79:513-516.
29. Kaplan J, Sarnaik S, Gitlin J, Lusher J: Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood 1984;64:308-310.
30. Mathiesen O, Lund L, Brodthagen U, Gandrup P, Grunnet N, Balslev I, Jersild C: The effect of previous blood transfusion on lymphocyte subsets and natural killer cell function in patients with colorectal cancer. Vox Sang 1994;67:36-41.
31. Ninomiya M: Study on the induction of immunological suppression by blood transfusion. J Jpn Surg Soc 1986;87:1380-1390.
32. Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996;84:732-747.
33. Omokawa S, Notoya T, Nagai I, Watanabe Y, Nakagawa S, Tobe S, Mori N, Yoshioka N, Miura AB: Analysis of the usage of concentrated red cells stored in MAP solution in comparison with ordinary concentrated red cells. Jpn J Trans Med 1993;39:634-639.
34. Donegan E, Stuart M, Niland JC, Sacks HS, Azen SP, Dietrich SL, Faucett C, Fletcher MA, Kleinman SH, Operskalski EA, Perkins HA, Pindyck J, Schiff ER, Sites DP, Tomasulo PA, Mosley JW: infection with human immunode-ficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. Ann Intern Med 1990;113:733-739.
35. Ebihara T, Koyama S, Fukao K, Osuga T: Lymphokine-activated suppressor (LAS) cells in patients with gastric carcinoma. Cancer Immunol Immunother 1989;28:218-224.
36. Toge T, Kegoya Y, Yamaguchi Y, Baba N, Kuninobu H, Takayama T, Yanagawa E, Hattori T: Surgical stress and immunosuppression in cancer patients. Jpn J Cancer Chemother 1989;16:115-1121.
37. Tanaka N, Yoshihara H, Ono M, Moritani T, Terasawa A, Beika T, Mannami T, Konaga E, Mimura H, Kunzo O: Post-operative suppression of natural killer activity. Jpn J Surg 1987;84:203-210.